Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID‐19‐associated organ failure

The use of mesenchymal stem cells (MSC) derived from several sources has been suggested as a major anti‐inflammation strategy during the recent outbreak of coronavirus‐19 (COVID‐19). As the virus enters the target cells through the receptor ACE2, it is important to determine if the MSC population tr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cells Transl Med
Autori principali: Desterke, Christophe, Griscelli, Frank, Imeri, Jusuf, Marcoux, Paul, Lemonnier, Thomas, Latsis, Theodoros, Turhan, Ali G., Bennaceur‐Griscelli, Annelise
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Enabling Technologies for Cell‐based Clinical Translation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753753/
https://ncbi.nlm.nih.gov/pubmed/33237619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0189
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi